revmed.com (RVMD): Net earnings per share growth forecast for next year

Corporate emblem and logo of RevMed (RVMD)

The stability of Revolution Medicines (RVMD) is underpinned by colossal R&D expenditures and patent protection. However, the lack of recurring revenue and FDA risks create a need for capital, although demand for cancer therapy remains independent of economic conditions. Changes in the consensus net income growth estimate demonstrate a revision of analyst models, while the 68.20 mark reflects fresh data on earnings expectations.

RVMD: Revolution Medicines Corp Expected net earnings per share growth next year 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for Revolution Medicines Inc (RVMD)

- share price and consensus valuation forecast:
Summary company analysis:Revolution Medicines Corp
Core merchandise of Revolution Medicines, Inc.

Revolution Medicines' independence from economic cycles makes the success of clinical trials a key value catalyst, which directly impacts consensus earnings forecasts. This chart of the company's expected EPS growth for the coming year reflects the speed at which institutional investors revise their estimates, capturing the acceleration or deceleration of fundamental momentum prior to the release of official financial reports, allowing investors to gauge market sentiment in advance.

Main competitors

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Earnings growth forecast for next year AAPG|Expected earnings per share growth for next year CG Oncology CGON|Net earnings per share growth forecast for next year UroGen URGN|Consensus forecast of earnings per share growth for next year Bicara Bio (BCAX)|PSNL - Net earnings per share growth forecast for next year|ERAS - Earnings growth forecast for next year|DCTH: Earnings growth forecast for next year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth forecast for next year|Expected earnings per share growth for next year AURA|Expected net earnings per share growth next year candeltx.com CADL|Earnings growth forecast for next year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ACTU (Actuate Therapeutics Inc)|Expected earnings per share trend next year CTOR|tuhurabio.com - Earnings growth forecast for next year|Expected earnings per share trend next year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Net earnings per share growth forecast for next year|WHWK - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year tscan.com|CSBR: Expected earnings per share trend next year|Net earnings per share growth forecast for next year XBiotech USA (XBIT)|CVM: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year ostherapies.com OSTX|Projected earnings per share increase next year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year